ACE inhibitor indicated in patients 55 years or older at high risk of developing a major cardiovascular event because of a history of coronary artery disease, stroke, peripheral vascular disease or diabetes that is accompanied by at least one other cardiovascular risk factor to reduce the risk of myocardial infraction, stroke or death from cardiovascular causes.